The Gateway Pundit -KILLER FAUCI: Even Developing Nations Algeria, India, Indonesia, Cuba That Used HCQ Fared Better than US in Treating Coronavirus — By an Average of 79% Better!

Source: The Gateway Pundit Author: Jim Hoft

The liberal mainstream media can’t hide this truth from the public forever.

The latest international testing of hydroxychloroquine treatment of coronavirus shows countries that had early use of the drug had a 79% lower mortality rate than countries that banned the use of the safe malaria drug.

This means that Dr. Fauci, Dr. Birx, the CDC, the liberal fake news media and the tech giants have been pushing a lie that has had deadly consequences!

America has lost (reportedly) over 150,000 lives.

That could have been lowered by possibly 80% if HCQ use would have been promoted in the US!

We are talking over 100,000 American lives could have been saved!

Here is the website that has compiled all of this international data.

Even developing nations Ukraine, Greece, Cuba, Morocco, Indonesia and Algeria fared better than the US under Dr. Fauci!

Over 100,000 US deaths could have been prevented!
This is mass murder.

Jim Hoft

To this day Dr. Fauci, Dr. Birx, the CDC and the FDA continue to refuse to promote the use of HCQ in the early treatment of Covid-19.


Related: The Gateway Pundit – JAIL FAUCI: New Report Compares Turkey COVID Treatment with HCQ vs. USA Without HCQ and the Results Are Crystal Clear –

France Soir: Efficacy of hydroxychloroquine confirmed in 3451 Italian patients. 30% reduction in mortality.

National Pulse: Hidden FDA Doc Explains Why “Liar” Fauci Opposes Hydroxychloroquine, Top Doctors Explain

Big Tech Silencing Physicians: A Very Dangerous Road for American Medicine

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »